FDA Inspection 1047621 — Hubei Haosun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Haosun Pharmaceutical Co., Ltd. on Mar 9, 2018 in Ezhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 9, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)